Arrowroot Family Office’s Eli Lilly LLY Stock Holding History

Arrowroot Family Office’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.38M	Buy	1,502 +46	+3%	+$46.6K	0.46%	51
2025 Q4	$1.56M	Buy	1,456 +29	+2%	+$27.7K	0.57%	42
2025 Q3	$1.09M	Buy	1,427 +77	+6%	+$57.3K	0.43%	53
2025 Q2	$1.05M	Buy	+1,350	New	+$1.05M	0.47%	50
2024 Q4	$1.03M	Buy	1,330 +1	+0.1%	+$828	0.53%	50
2024 Q3	$1.18M	Buy	1,329 +1	+0.1%	+$899	0.69%	41
2024 Q2	$1.2M	Sell	1,328 -5	-0.4%	-$4K	0.77%	33
2024 Q1	$1.04M	Buy	1,333 +1	+0.1%	+$712	0.66%	41
2023 Q4	$776K	Buy	1,332 +1	+0.1%	+$584	0.55%	49
2023 Q3	$715K	Buy	1,331 +10	+0.8%	+$5.15K	0.56%	49
2023 Q2	$619K	Buy	1,321 +2	+0.2%	+$839	0.47%	60
2023 Q1	$453K	Buy	+1,319	New	+$445K	0.39%	67

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Arrowroot Family Office's LLY Position: Q1 2026 in Review

Arrowroot Family Office increased its Eli Lilly (LLY) stake by 3.2% in Q1 2026, buying an estimated $46.6K and bringing the position to 1,502 shares worth $1.38M. The position accounts for 0.46% of the portfolio, ranked #51.

Arrowroot Family Office first reported a position in LLY in Q1 2023 and has held it in 12 quarters since. The position peaked at $1.56M in Q4 2025. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Arrowroot Family Office held 1,502 shares of Eli Lilly worth $1.38M as of Q1 2026.
Arrowroot Family Office bought 46 Eli Lilly shares in Q1 2026, an estimated $46.6K.
Eli Lilly made up 0.46% of Arrowroot Family Office's portfolio in Q1 2026, its #51 holding.
Arrowroot Family Office first reported a position in Eli Lilly in Q1 2023 and has held it in 12 quarters since.
Arrowroot Family Office's Eli Lilly position peaked at $1.56M in Q4 2025.
4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Arrowroot Family Office's 13F filing for Q1 2026, filed 14 May 2026.